Control of human breast cancer by estrogen, growth factors, and oncogenes
- 1 January 1988
- book chapter
- Published by Springer Nature
- Vol. 40, 119-165
- https://doi.org/10.1007/978-1-4613-1733-3_6
Abstract
No abstract availableKeywords
This publication has 101 references indexed in Scilit:
- Metabolism of steroid-modifying anticancer agentsPharmacology & Therapeutics, 1988
- Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature, 1986
- Negative regulators of cell growthTrends in Biochemical Sciences, 1986
- Immunotoxins: redirecting nature's poisonsCell, 1985
- MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGFBiochemical and Biophysical Research Communications, 1985
- Amplified expression of p21 ras protein in hormone-dependent mammary carcinomas of humans and rodentsBiochemical and Biophysical Research Communications, 1985
- Endocytosis of polypeptides and their receptorsTrends in Pharmacological Sciences, 1985
- Immunochemical studies of estrogen receptorsJournal of Steroid Biochemistry, 1984
- 1,25-dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line (MCF 7 cells)Biochemical and Biophysical Research Communications, 1980
- Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7)Biochemical and Biophysical Research Communications, 1979